Exelixis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Exelixis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
1,147
Employees1,147
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
1,147
Employees1,147

EXEL Key Statistics

Market cap
11.85B
Market cap11.85B
Price-Earnings ratio
18.60
Price-Earnings ratio18.60
Dividend yield
Dividend yield
Average volume
2.68M
Average volume2.68M
High today
$44.95
High today$44.95
Low today
$43.85
Low today$43.85
Open price
$44.91
Open price$44.91
Volume
1.52M
Volume1.52M
52 Week high
$49.62
52 Week high$49.62
52 Week low
$31.90
52 Week low$31.90

Stock Snapshot

The current Exelixis(EXEL) stock price is $44.17, with a market capitalization of 11.85B. The stock trades at a price-to-earnings (P/E) ratio of 18.60.

During the trading session on 2025-11-29, Exelixis(EXEL) shares reached a daily high of $44.95 and a low of $43.85. At a current price of $44.17, the stock is +0.7% higher than the low and still -1.7% under the high.

Trading volume for Exelixis(EXEL) stock has reached 1.52M, versus its average volume of 2.68M.

Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.

Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.

EXEL News

Nasdaq 1d
Friday 11/28 Insider Buying Report: EXEL, ONMD

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably...

Friday 11/28 Insider Buying Report: EXEL, ONMD
Simply Wall St 3d
Board Member’s $1.2 Million Share Buy Might Change the Case for Investing in Exelixis

Earlier this week, Exelixis board member David Johnson purchased 27,500 shares for approximately US$1.2 million, reinforcing interest in the company’s future di...

Board Member’s $1.2 Million Share Buy Might Change the Case for Investing in Exelixis
Simply Wall St 7d
Exelixis: Assessing the Stock’s Valuation After Its Recent Strong Run

Exelixis (EXEL) shares have delivered a roughly 10% gain over the past month, continuing a trend that has caught the interest of long-term investors. Recent ret...

Exelixis: Assessing the Stock’s Valuation After Its Recent Strong Run

Analyst ratings

50%

of 22 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.